Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: Secondary analyses of four pooled randomized controlled trials of duloxetine

Pain

Volumn 152, Issue 1, 2011, Pages 31-37

  Marangell, Lauren B ^a   Clauw, Daniel J ^b   Choy, Ernest ^c   Wang, Fujun ^a   Shoemaker, Scarlett ^a   Bradley, Laurence ^d   Mease, Philip ^e,f   Wohlreich, Madelaine M ^a  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d The University of Alabama at Birmingham   (United States)

^e SWEDISH MEDICAL CENTER   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Comorbid; Comorbidity; Duloxetine; Fibromyalgia; Major depressive disorder

Indexed keywords

DULOXETINE; PLACEBO;

ADULT; ANALGESIA; ARTICLE; BECK DEPRESSION INVENTORY; BRIEF PAIN INVENTORY; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FIBROMYALGIA; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD; OUTCOME ASSESSMENT; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; THERAPY EFFECT;

ADULT; AFFECT; ANTIDEPRESSIVE AGENTS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; THIOPHENES;

EID: 78650418821     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2010.05.029     Document Type: Article

References (56)

1. D.F. Alwin, and R.M. Hauser The decomposition of effects in path analysis Am Sociol Rev 40 1975 37 47
2. Association American Psychiatric Diagnostic and statistical manual of mental disorders 4th ed. 1994 American Psychiatric Association Washington (DC)
3. J.G. Anderson, and F.B. Evans Causal models in educational research: recursive models Am Ed Res J 11 1974 29 39
4. J. Angst, A. Delini-Stula, M. Stabl, and H.H. Stassen Is a cut-off score a suitable measure of treatment outcome in short-term trials in depression? A methodological meta-analysis Hum Psychopharmacol Clin Exp 8 1993 311 317
5. L.M. Arnold Duloxetine and other antidepressants in the treatment of patients with fibromyalgia Pain Med 8 2007 S63 S74
6. L.M. Arnold, J.I. Hudson, E.V. Hess, A.E. Ware, D.A. Fritz, M.B. Auchenbach, L.O. Starck, and P.E. Keck Jr. Family study of fibromyalgia Arthritis Rheum 50 2004 944 952
7. L.M. Arnold, J.I. Hudson, F. Wang, M.M. Wohlreich, A. Prakash, D.K. Kajdasz, and A.S. Chappell Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder Clin J Pain 25 2009 461 468
8. L.M. Arnold, Y. Lu, L.J. Crofford, M. Wohlreich, M.J. Detke, S. Iyengar, D.J. Goldstein for the Duloxetine Fibromyalgia Trial Group A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder Arthritis Rheum 50 2004 2974 2984
9. L.M. Arnold, A. Rosen, Y. Lu Pritchett, D.N. D'Souza, D.J. Goldstein, S. Iyengar, and J.F. Wernicke A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder Pain 119 2005 5 15
10. B.A. Arnow, E.M. Hunkeler, C.M. Blasey, J. Lee, M.J. Constantino, B. Fireman, H.C. Kraemer, R. Dea, R. Robinson, and C. Hayward Comorbid depression, chronic pain, and disability in primary care Psychosom Med 68 2006 262 268
11. V.R. Bacharach, and A.A. Baumeister Direct and indirect effects of maternal intelligence, maternal age, income and home environment on intelligence of preterm, low-birth-weight children J Appl Dev Psychol 19 1998 361 375
12. M.J. Bair, R.L. Robinson, G.J. Eckert, P.E. Stang, T.W. Croghan, and K. Kroenke Impact of pain on depression treatment response in primary care Psychosom Med 66 2004 17 22
13. M.J. Bair, R.L. Robinson, W. Katon, and K. Kroenke Depression and pain comorbidity a literature review Arch Intern Med 163 2003 2433 2445
14. S. Banks, and R.D. Kerns Explaining high rates of depression in chronic pain: a diathesis-stress framework Psychol Bull 119 1996 95 110
15. A.I. Basbaum, and H.L. Fields Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry Annu Rev Neurosci 7 1984 309 338
16. A.T. Beck, R.A. Steer, R. Ball, and W. Ranieri Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients J Pers Assess 67 1996 588 597
17. S.K. Brannan, C.H. Mallinckrodt, E.B. Brown, M.M. Wohlreich, J.G. Watkin, and A.F. Schatzberg Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder J Psychiatr Res 39 2005 43 53
18. C.S. Burckhardt, S.R. Clark, and R.M. Bennett The fibromyalgia impact questionnaire: development and validation J Rheumatol 18 1991 728 733
19. K.L. Casey Toward a neurophysiology of pain Headache 8 1969 141 153
20. A.S. Chappell, L.A. Bradley, C. Wiltse, M.J. Detke, D.N. D'Souza, and M. Spaeth A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia Int J Gen Med 1 2009 91 102
21. D.S. Ciccone, and R.C. Grzesiak Cognitive dimensions of chronic pain Soc Sci Med 19 1984 1339 1345
22. D.J. Clauw Fibromyalgia: update on mechanisms and management J Clin Rheumatol 13 2007 102 109
23. C.S. Cleeland, and K.M. Ryan Pain assessment: global use of the Brief Pain Inventory Ann Acad Med Singapore 23 1994 129 138
24. Cymbalta Full Prescribing Information. www.Cymbalta.com [accessed 19.02.09].
25. M.C. Davis, A.J. Zautra, and J.W. Reich Vulnerability to stress in women among women in chronic pain from fibromyalgia and osteoarthritis Ann Behav Med 23 2001 215 226
26. S.W. Derbyshire Imaging the brain in pain Am Pain Soc Bull 1999 7 8
27. M.J. Detke, Y. Lu, D.J. Goldstein, R.K. McNamara, and M.A. Demitrack Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression J Psychiatr Res 36 2002 383 390
28. S.A. Epstein, G. Kay, D. Clauw, R. Heaton, D. Klein, L. Krupp, J. Kuck, V. Leslie, D. Masur, M. Wagner, R. Waid, and S. Zisook Psychiatric disorders in patients with fibromyalgia. A multicenter investigation Psychosomatics 40 1999 57 63
29. D. Fishbain Evidence-based data on pain relief with antidepressants Ann Med 32 2000 305 316
30. T. Giesecke, R.H. Gracely, D.A. Williams, M.E. Geisser, F.W. Petzke, and D.J. Clauw The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort Arthritis Rheum 52 2005 1577 1584
31. A.S. Goldberger, O.D. Duncan, Structural equation model in the social sciences 1973 Seminar Press New York
32. D.J. Goldstein, Y. Lu, M.J. Detke, T.C. Lee, and S. Iyengar Duloxetine vs. placebo in patients with painful diabetic neuropathy Pain 116 2005 109 118
33. R.H. Gracely, M.E. Geisser, T. Giesecke, M.A. Grant, F. Petzke, D.A. Williams, and D.J. Clauw Pain catastrophizing and neural responses to pain among persons with fibromyalgia Brain 127 2004 835 843
34. M. Hamilton A rating scale for depression J Neurol Neurosurg Psychiatry 23 1960 56 62
35. J.I. Hudson, D.L. Goldenberg, H.G. Pope Jr., P.E. Keck Jr., and L. Schlesinger Comorbidity of fibromyalgia with medical and psychiatric disorders Am J Med 92 1992 363 367
36. J.I. Hudson, M.S. Hudson, L.F. Pliner, D.L. Goldenberg, and H.G. Pope Jr. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study Am J Psychiatry 142 1985 441 446
37. K. Kroenke, M.J. Bair, T.M. Damush, J. Wu, S. Hoke, J. Sutherland, and W. Tu Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial JAMA 301 2009 2099 2110
38. K. Kroeke, J. Shen, T.E. Oxman, J.W. Williams, and A.J. Dietrich Impact of pain on the outcomes of depression treatment: results from the RESPECT trial Pain 134 2008 209 215
39. I.A. Lipkovich, W. Deberdt, J.G. Csernansky, B. Sabbe, R.S.E. Keefe, and S. Kollack-Walker Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy BMC Psychiatry 9 2009 44
40. Lu Yili An application of path analysis in the design of clinical trials ASA proceedings of the joint statistical meetings 2003 American Statistical Association Alexandra (VA) 2576 2582
41. P. Mease, L.M. Arnold, R. Bennett, A. Boonen, D. Buskila, S. Carville, A. Chappell, E. Choy, D. Clauw, D. Dadabhoy, M. Gendreau, D. Goldenberg, G. Littlejohn, S. Martin, P. Perera, J. Russell, L. Simon, M. Spaeth, D. Williams, and L. Crofford Fibromyalgia syndrome J Rheumatol 34 2007 1415 1425
42. R. Melzack, and P.D. Wall Pain mechanisms: a new theory Science 150 1965 971 979
43. M.J. Millan Descending control of pain Prog Neurobiol 66 2002 355 474
44. M. Offenbaecher, B. Bondy, S. de Jonge, K. Glatzeder, M. Kruger, P. Schoeps, and M. Ackenheil Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region Arthritis Rheum 42 1999 2482 2488
45. D.G.S. Perahia, Y.L. Pritchett, D. Desaiah, and J. Raskin Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect? Int Clin Psychopharmacol 21 2006 311 317
46. F. Petzke, R.H. Gracely, K.M. Park, K. Ambrose, and D.J. Clauw What do tender points measure? Influence of distress on 4 measures of tenderness J Rheumatol 30 2003 567 574
47. R.D. Retherford, and M.K. Choe Statistical methods for causal analysis 1993 Wiley New York
48. I.J. Russell, J.E. Michalek, G.A. Vipario, E.M. Fletcher, M.A. Javors, and C.A. Bowden Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/ fibrositis syndrome J Rheumatol 19 1992 104 109
49. J. Russell, P.J. Mease, T.R. Smith, D.K. Kajdasz, M.M. Wohlreich, M.J. Detke, D.J. Walker, A.S. Chappell, and L.M. Arnold Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial Pain 136 2008 432 444
50. D.A. Seminowicz, and K.D. Davis Cortical responses to pain in healthy individuals depends on pain catastrophizing Pain 120 2006 297 306
51. N.K.Y. Tag, P.M. Salkovskis, A. Hodges, K.J. Wright, M. Hanna, and J. Hester Effects of mood on pain responses and pain tolerance: an experimental study in chronic back pain patients Pain 138 2008 392 401
52. I. Tracey, and P.W. Mantyh The cerebral signature for pain perception and its modulation Neuron 55 2007 377 391
53. R.D. Treede, D.R. Kenshalo, R.H. Gracely, and A.K. Jones The cortical representation of pain Pain 79 1999 105 111
54. T. Vishne, L. Fostick, A. Silberman, M. Kupchick, A. Rubinow, H. Amital, and D. Amital Fibromyalgia among major depression disorder females compared to males Rheumatol Int 28 2008 831 836
55. R. Wassem, M. McDonald, and J. Racine Fibromyalgia: patient perspectives on symptoms, symptom management and provider utilization Clin Nurse Spec 16 2002 24 28
56. F. Wolfe, H.A. Smythe, M.B. Yunus, R.M. Bennett, C. Bombardier, D.L. Goldenberg, P. Tugwell, S.M. Campbell, M. Abeles, P. Clark, A.G. Fam, S.J. Farber, J.J. Flechtner, C.M. Franklin, R.A. Gatter, D. Hamaty, J. Lessard, A.S. Lichtbroun, A.T. Masi, G.A. McCain, W.J. Reynolds, T.J. Romano, I.J. Russell, and R.P. Sheon The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee Arthritis Rheum 33 1990 160 172